Posted 25 June, 2021
Elevation Oncology, Inc. IPO completed
IPO completed detected for ticker Nasdaq:ELEV in a 424B1 filed on 25 June, 2021.
This is an initial public offering of shares of common stock by Elevation Oncology, Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Elevation Oncology, Inc.
Health Care/Life Sciences • Biotechnology
Elevation Oncology, Inc. is a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.Market Cap
$204M
View Company Details
$204M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.